Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Piotr Rutkowski

Piotr Rutkowski
Country

Poland

Address
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw

Piotr Rutkowski is Professor of Surgical Oncology at the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Warsaw, Poland. He obtained his medical degree from the Medical University of Lodz, Poland and received his PhD, in 2001, from the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology for his work on cytokine levels in patients with soft tissue and bone sarcomas.

Dr Rutkowski is currently Head of the Department of Soft Tissue/Bone Sarcoma and Melanoma and the Plenipotentiary Director of the Institute for Clinical Trials at the Maria Sklodowska-Curie Memorial Cancer Center. He has participated in several investigator-driven trials in melanoma and sarcoma. He is also Coordinator of the Polish Clinical GIST Registry, and a reviewer for several international scientific journals, as well as a member of the Editorial Board of Annals of Surgical Oncology and European Journal of Surgical Oncology.

Dr Rutkowski is an active member of the EORTC Soft Tissue and Bone Sarcoma Group, where he chaired the Local Treatment Subcommittee and the Membership Committee of the EORTC Board. He is also an active member of the EORTC Melanoma Group and the Global Melanoma Task Force. He is a member of several Polish and international scientific societies (Board member and President of the Polish Society Surgical Oncology and Ex-member of the Board of Directors of the Connective Tissue Oncology Society).

Dr Rutkowski has authored or co-authored over 100 scientific papers in Polish and international journals (with an impact factor of above 1200, index-H: 32), and is co-author of national and international recommendations for sarcoma and melanoma. He is working very closely with national patient advocacy groups for GIST and sarcoma and is Chairman of the Melanoma Academy in Poland.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings